Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Delayed BME Other stock markets 06:33:16 29/07/2026 pm IST			5-day change	1st Jan Change
60.05 ^EUR	+0.67%		+6.85%	-5.43%

23/07	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
23/07	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
LABORATORIOS FARMACEUTICOS ROVI, S.A.	347.62Cr		BBB
ELI LILLY AND COMPANY	1,08900Cr		A
JOHNSON & JOHNSON	64TCr		BBB
ABBVIE INC.	47TCr		AA	-
ROCHE HOLDING AG	36TCr		AA
NOVARTIS AG	30TCr		AAA
ASTRAZENECA PLC	27TCr		A
NOVO NORDISK A/S	23TCr		A
AMGEN INC.	21TCr		A
GILEAD SCIENCES, INC.	17TCr		AA
PFIZER INC.	14TCr		A
BRISTOL-MYERS SQUIBB COMPANY	13TCr		A
VERTEX PHARMACEUTICALS INCORPORATED	12TCr		AA
SANOFI	11TCr		AA
GSK PLC	11TCr		AA
CHUGAI PHARMACEUTICAL CO., LTD.	7.03TCr		AA
ALLERGAN PLC	6.37TCr	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	5.6TCr		AA
BAYER AG	5.26TCr		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	5.2TCr		AA
Average	23.22TCr		AA
Weighted average by Cap.			AA